COVID-19 and hospital management costs: the Italian experience

被引:15
作者
Foglia, Emanuela [1 ]
Ferrario, Lucrezia [1 ]
Schettini, Fabrizio [1 ]
Pagani, M. Beatrice [1 ]
Dalla Bona, Martina [1 ]
Porazzi, Emanuele [1 ]
机构
[1] Carlo Cattaneo LIUC Univ, Healthcare Datasci Lab HD LAB, Ctr Hlth Econ Social & Hlth Care Management, I-21053 Castellanza, Italy
关键词
COVID-19; Economic evaluation; Time-driven activity-based costing analysis; Italy; Hospitalization costs; HEALTH-CARE;
D O I
10.1186/s12913-022-08365-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background This article investigates the hospital costs related to the management of COVID-19 positive patients, requiring a hospitalization (from the positivity confirmation to discharge, including rehabilitation activities). Methods A time-driven activity-based costing analysis, grounding on administrative and accounting flows provided by the management control, was implemented to define costs related to the hospital management of COVID-19 positive patients, according to real-word data, derived from six public Italian Hospitals, in 2020. Results Results reported that the higher the complexity of care, the higher the hospitalization cost per day (low-complexity = euro475.86; medium-complexity = euro700.20; high-complexity = euro1,401.65). Focusing on the entire clinical pathway, the overall resources absorption, with the inclusion of rehabilitation costs, ranged from 6,198.02euro to 32,141.20euro, dependent from the patient's clinical condition. Conclusions Data could represent the baseline cost for COVID-19 hospital management, thus being useful for the further development of proper reimbursement tariffs devoted to hospitalized infected patients.
引用
收藏
页数:10
相关论文
共 34 条
[1]  
Alves Rafael J Vargas, 2018, Value Health Reg Issues, V17, P142, DOI 10.1016/j.vhri.2018.06.001
[2]   Data-based analysis, modelling and forecasting of the COVID-19 outbreak [J].
Anastassopoulou, Cleo ;
Russo, Lucia ;
Tsakris, Athanasios ;
Siettos, Constantinos .
PLOS ONE, 2020, 15 (03)
[3]  
Athanasakis K, 2020, VALUE HEALTH, V23, pS647
[4]   Advances in Value -Based Healthcare by the Application of Time -Driven -Based for A Review [J].
Beck da Silva Etges, Ana Paula ;
Ruschel, Karen Brasil ;
Polanczyk, Carisi Anne ;
Urman, Richard D. .
VALUE IN HEALTH, 2020, 23 (06) :812-823
[5]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[6]  
Bernardo J. M., 2008, BAYESIAN THEORY, DOI DOI 10.1002/9780470316870
[7]  
Celine M, 2014, HLTH HEALTHCARE ASSE
[8]   Epidemiological and economic impact of COVID-19 in the US [J].
Chen, Jiangzhuo ;
Vullikanti, Anil ;
Santos, Joost ;
Venkatramanan, Srinivasan ;
Hoops, Stefan ;
Mortveit, Henning ;
Lewis, Bryan ;
You, Wen ;
Eubank, Stephen ;
Marathe, Madhav ;
Barrett, Chris ;
Marathe, Achla .
SCIENTIFIC REPORTS, 2021, 11 (01)
[9]   Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis [J].
Congly, Stephen E. ;
Varughese, Rhea A. ;
Brown, Crystal E. ;
Clement, Fiona M. ;
Saxinger, Lynora .
SCIENTIFIC REPORTS, 2021, 11 (01)
[10]   Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations [J].
Dawoud, Dalia M. ;
Soliman, Khaled Y. .
VALUE IN HEALTH, 2020, 23 (11) :1409-1422